Investors

IR Overview

SEC Filing Details

Document Details

Form
Filing Date
Oct 1, 2019
Document Date
Oct 1, 2019
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Adaptimmune Therapeutics Plc
Issuer
Adaptimmune Therapeutics PLC
Filer
Garone Michael